|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Apr 1, 2023
|
FY2022
12 months to Apr 2, 2022
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Income (loss) from discontinued operations, net of tax | |||||
| Income (loss) from continuing operations, net of tax | |||||
| Adjustments to reconcile net income (loss) to cash provided by operating activities: | |||||
| Impairment of goodwill and intangible assets | |||||
| Depreciation, amortization and other asset write-downs | |||||
| Reduction in the carrying amount of right-of-use assets | |||||
| Stock-based compensation | |||||
| Provision for doubtful accounts | |||||
| Pension expense in excess of (less than) contributions | |||||
| Pension termination asset reversion, net | |||||
| Deferred income taxes | |||||
| Write-off of income tax receivables and interest | |||||
| Loss on extinguishment of debt | |||||
| Gain on sale of business | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Income taxes | |||||
| Accrued liabilities | |||||
| Operating lease right-of-use assets and liabilities | |||||
| Other assets and liabilities | |||||
| Cash provided by operating activities - continuing operations | |||||
| Cash provided by operating activities - discontinued operations | |||||
| Cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Business acquisitions, net of cash received | |||||
| Proceeds from sale of businesses, net of cash sold | |||||
| Proceeds from sale of assets | |||||
| Proceeds from sale of short-term investments | |||||
| Capital expenditures | |||||
| Software purchases | |||||
| Other, net | |||||
| Cash provided (used) by investing activities - continuing operations | |||||
| Cash used by investing activities - discontinued operations | |||||
| Cash provided (used) by investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Contingent consideration payment | |||||
| Net increase (decrease) in short-term borrowings | |||||
| Payments on long-term debt | |||||
| Payment of debt issuance costs | |||||
| Proceeds from long-term debt | |||||
| Share repurchases | |||||
| Cash dividends paid | |||||
| Proceeds from issuance of Common Stock, net of (payments) for tax withholdings | |||||
| Cash used by financing activities | |||||
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash — beginning of year | |||||
| Cash, cash equivalents and restricted cash — end of year | |||||
| Balances per Consolidated Balance Sheets: | |||||
| Cash and cash equivalents | |||||
| Other current assets | |||||
| Current and other assets of discontinued operations | |||||
| Other assets | |||||
Loading...